SPX 6,124.35 ▲ 0.47%DJI 44,210.18 ▼ 0.12%CCMP 19,875.02 ▲ 0.72%SX5E 5,231.77 ▲ 0.24%UKX 8,402.11 ▼ 0.22%NKY 39,870.50 ▲ 0.78%EURUSD 1.0842 ▼ 0.19%USGG10YR 4.31 ▲ 0.94%CL1 71.82 ▼ 0.88%XAU 2,685.40 ▲ 0.42%XBT 97,250.00 ▲ 1.93%SPX 6,124.35 ▲ 0.47%DJI 44,210.18 ▼ 0.12%CCMP 19,875.02 ▲ 0.72%SX5E 5,231.77 ▲ 0.24%UKX 8,402.11 ▼ 0.22%NKY 39,870.50 ▲ 0.78%EURUSD 1.0842 ▼ 0.19%USGG10YR 4.31 ▲ 0.94%CL1 71.82 ▼ 0.88%XAU 2,685.40 ▲ 0.42%XBT 97,250.00 ▲ 1.93%
 

← Persons Index

Zhong Huijuan
Rank #172 · Healthcare

Zhong Huijuan

Pharmaceuticals · China

Net worth$16.7B
Today−$834M
7 days−$1.8M
30 days−$533M

Net worth, last 30 days

Low $16.7BHigh $19.0B

Biography

Zhong Huijuan is the chairman and CEO of Chinese drugmaker Hansoh Pharmaceutical Group, which produces oncology, psychoactive, antidiabetic and other drugs.

Zhong's husband, Sun Piaoyang, is also a billionaire and leads Jiangsu Hengrui Pharmaceuticals, which is dual-listed in Shanghai and Hong Kong.

Their daughter, Sun Yuan, is Hansoh's executive director.

Headquartered in the Chinese coastal city of Lianyungang, Hansoh went public on the Hong Kong Stock Exchange in 2019.

In 2026, the company announced a $15 billion deal where it will jointly develop several antibody drugs with Swiss multinational Roche. Hansoh also has billion-dollar deals with pharmaceutical giants including Merck.

Holdings

CompanyTickerSharesValue
Hansoh Pharmaceutical Group3692-HK3,902,210,000$126.5B
Jiangsu Hengrui Medicine600276-CN110,750,000$5.2B
Private assets & other$623M

Public holdings ≈ $131.7B. Holdings may include options and overlap between rows.